Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 393064, 6 pages
http://dx.doi.org/10.1155/2014/393064
Research Article

TAZ Is Highly Expressed in Gastric Signet Ring Cell Carcinoma

1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing 210008, China
2Pangaea Biotech, USP Dexeus University Institute, Barcelona, Spain
3Department of General Surgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China

Received 16 November 2013; Revised 7 January 2014; Accepted 17 January 2014; Published 24 February 2014

Academic Editor: Koichi Handa

Copyright © 2014 Guofeng Yue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, p. 134, 2011. View at Google Scholar
  2. J. Y. Cho, J. Y. Lim, J. H. Cheong et al., “Gene expression signature-based prognostic risk score in gastric cancer,” Clinical Cancer Research, vol. 17, no. 7, pp. 1850–1857, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. G. Hass, U. Smith, C. Jäger et al., “Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren's): single-center experience of 160 cases,” Onkologie, vol. 34, no. 12, pp. 682–686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Taghavi, S. N. Jayarajan, A. Davey et al., “Prognostic significance of signet ring gasrtric cancer,” Journal of Clinical Oncology, vol. 30, no. 28, pp. 3493–3498, 2012. View at Publisher · View at Google Scholar
  5. M. Zhang, G. Zhu, H. Zhang, H. Gao, and Y. Xue, “Clinicopathologic features of gastric carcinoma with signet ring cell histology,” Journal of Gastrointestinal Surgery, vol. 14, no. 4, pp. 601–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Li, S. Kim, J. F. Lai et al., “Advanced gastric carcinoma with signet ring cell histology,” Oncology, vol. 72, no. 1-2, pp. 64–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Piessen, M. Messager, E. Leteurtre, T. Jean-Pierre, and C. Mariette, “Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation,” Annals of Surgery, vol. 250, no. 6, pp. 878–887, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Kanai, P. A. Marignani, D. Sarbassova et al., “TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins,” EMBO Journal, vol. 19, no. 24, pp. 6778–6791, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Murakami, M. Nakagawa, E. N. Olson, and O. Nakagawa, “A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 18034–18039, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Di Palma, B. D'Andrea, G. L. Liguori et al., “TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation,” Experimental Cell Research, vol. 315, no. 2, pp. 162–175, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Varelas, R. Sakuma, P. Samavarchi-Tehrani et al., “TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal,” Nature Cell Biology, vol. 10, no. 7, pp. 837–848, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Q.-Y. Lei, H. Zhang, B. Zhao et al., “TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway,” Molecular and Cellular Biology, vol. 28, no. 7, pp. 2426–2436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Zhou, Y. Hao, N. Liu, L. Raptis, M.-S. Tsao, and X. Yang, “TAZ is a novel oncogene in non-small cell lung cancer,” Oncogene, vol. 30, no. 18, pp. 2181–2186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Xie, L. Zhang, C. S. He et al., “Prognostic significance of TAZ expression in resected non-small cell lung cancer,” Journal of Thoracic Oncology, vol. 7, no. 5, pp. 799–807, 2012. View at Publisher · View at Google Scholar
  15. T. De Cristofaro, T. Di Palma, A. Ferraro et al., “TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma,” European Journal of Cancer, vol. 47, no. 6, pp. 926–933, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. F. Yuen, C. M. McCrudd, Y. H. Huang et al., “TAZ Expression as prognostic indicator in colorectal cancer,” PLoS ONE, vol. 8, no. 1, Article ID 54211, 2013. View at Google Scholar
  17. D. Zhao, X. Zhi, Z. Zhou, and C. Chen, “TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis,” Carcinogenesis, vol. 33, no. 1, pp. 59–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Lai, K. C. Ho, Y. Hao, and X. Yang, “Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF,” Cancer Research, vol. 71, no. 7, pp. 2728–2738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Cordenonsi, F. Zanconato, L. Azzolin et al., “The hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells,” Cell, vol. 147, no. 4, pp. 759–772, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. K. C. Zimmermann, M. Sarbia, A.-A. Weber, F. Borchard, H. E. Gabbert, and K. Schrör, “Cyclooxygenase-2 expression in human esophageal carcinoma,” Cancer Research, vol. 59, no. 1, pp. 198–204, 1999. View at Google Scholar · View at Scopus
  21. J. Wei, C. Costa, Y. Ding et al., “MRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer,” Journal of the National Cancer Institute, vol. 103, no. 20, pp. 1552–1556, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Pan, “The hippo signaling pathway in development and cancer,” Developmental Cell, vol. 19, no. 4, pp. 491–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Zhao, L. Li, Q. Lei, and K.-L. Guan, “The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version,” Genes and Development, vol. 24, no. 9, pp. 862–874, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. W. C. Siew, J. L. Chun, K. Guo et al., “A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells,” Cancer Research, vol. 68, no. 8, pp. 2592–2598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Zhang, C.-Y. Liu, Z.-Y. Zha et al., “TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition,” Journal of Biological Chemistry, vol. 284, no. 20, pp. 13355–13362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K. P. L. Bhat, K. L. Salazar, V. Balasubramaniyan et al., “The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma,” Genes and Development, vol. 25, no. 24, pp. 2594–2609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Y. Lim, S. O. Yoon, S. Y. Seol et al., “Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer,” World Journal of Gastroenterology, vol. 18, no. 30, pp. 4037–4043, 2012. View at Publisher · View at Google Scholar
  28. M. Aoki, S. Ishigami, Y. Uenosono et al., “Expression of BMP-7 in human gastric cancer and its clinical significance,” British Journal of Cancer, vol. 104, no. 4, pp. 714–718, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Yoshii, H. Tanaka, M. Ohira et al., “Expression of Forkhead box P3 in tumor cells causes immunregulatory function of signet ring cell carcinoma of the stomach,” British Journal of Cancer, vol. 106, no. 10, pp. 1668–1674, 2012. View at Publisher · View at Google Scholar